11-119029222-C-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PM5PP3_ModeratePP5_Very_Strong
The ENST00000330775.9(SLC37A4):c.148G>A(p.Gly50Arg) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000000685 in 1,460,886 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Uncertain significancein ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G50E) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000330775.9 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC37A4 | NM_001164277.2 | c.148G>A | p.Gly50Arg | missense_variant, splice_region_variant | 3/11 | ENST00000642844.3 | |
SLC37A4 | NM_001164279.2 | c.-172+170G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC37A4 | ENST00000330775.9 | c.148G>A | p.Gly50Arg | missense_variant, splice_region_variant | 2/10 | 5 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460886Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726716
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Glucose-6-phosphate transport defect Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Nov 21, 2023 | Variant summary: SLC37A4 c.148G>A (p.Gly50Arg) results in a non-conservative amino acid change in the encoded protein sequence. Three of three in-silico tools predict a damaging effect of the variant on protein function. As the variant alters a conserved last nucleotide of exon 3 adjacent to the intronic splicing donor site, several computational tools predict a significant impact on normal splicing: Three predict the variant abolishes the canonical 5' splicing donor site. One predicts the variant weakens the canonical 5' splicing donor site. However, these predictions have yet to be confirmed by functional studies. The variant was absent in 152240 control chromosomes (gnomAD v4.0). c.148G>A has been reported in the literature in at-least one individual affected with Glycogen Storage Disease Type Ib (example, Choi_2017) although a different nucleotide change at the same location resulting in the same amino acid change has been reported among the pathogenic spectrum of variants in the SLC37A4 gene. To our knowledge, no variant specific experimental evidence demonstrating an impact on protein function has been reported, however, the c.148G>C variant that results in the same amino acid change (p.Gly50Arg), abolishes the microsomal G6P uptake activity, and compromises G6PT stability (cited in Choi_2017). The following publications have been ascertained in the context of this evaluation (PMID: 30956637, 28224773). No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Nov 20, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at